Skip to content

Effects of euglena cosmetic ingredients for Skin Conditions

Effects of euglena cosmetic ingredients for Skin Conditions - Effects of euglena cosmetic ingredients for Skin Conditions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052728
Enrollment
12
Registered
2024-11-12
Start date
2023-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult

Interventions

Apply test cosmetics (oil) to the designated left or right half face during 1 month.

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Men and women aged 20 to 64. 2.Individuals who practice simple skin care routines after cleansing. 3.Those who have concerns with dry skin. 4.Participants who do not typically develop hay fever during the trial period. 5.Individuals with no history of allergic reactions to cosmetics. 6.Those who can visit the designated facility on the scheduled trial dates. 7.Participants who can strictly adhere to the designated trial product usage conditions. 8.Subjects whose written informed consent has been obtained

Exclusion criteria

Exclusion criteria: 1.Individuals with a history of skin diseases. 2.Those who are pregnant or breastfeeding. 3.Individuals currently taking or applying medications that may affect the results of the trial. 4.Those who have received cosmetic medical treatments within 4 weeks prior to the start of the trial. 5.Individuals who have undergone skin care treatments within 4 weeks prior to the start of the trial. 6.Those with extensive acne, wounds, warts, or similar issues on the area where the product is to be applied, making them unsuitable as subjects. 7.Others whom the trial's principal investigator deems inappropriate for the study.

Design outcomes

Primary

MeasureTime frame
Transepidermal Water Loss Stratum Corneum Moisture Sebum Melanin Skin Viscoelasticity VISIA Imaging Evaluation

Secondary

MeasureTime frame
Subjective Skin Evaluation Criteria

Countries

Japan

Contacts

Public ContactAyaka Nakashima

Euglena Co.,Ltd. Lifescience Research Institute

nakashima@euglena.jp03-3453-4907

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026